These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 9376597)
1. Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity. Ott MM; Bartkova J; Bartek J; Dürr A; Fischer L; Ott G; Müller-Hermelink HK; Kreipe H Blood; 1997 Oct; 90(8):3154-9. PubMed ID: 9376597 [TBL] [Abstract][Full Text] [Related]
2. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections. Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535 [TBL] [Abstract][Full Text] [Related]
3. Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene. Swerdlow SH; Yang WI; Zukerberg LR; Harris NL; Arnold A; Williams ME Hum Pathol; 1995 Sep; 26(9):999-1004. PubMed ID: 7545645 [TBL] [Abstract][Full Text] [Related]
4. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1. Zukerberg LR; Benedict WF; Arnold A; Dyson N; Harlow E; Harris NL Blood; 1996 Jul; 88(1):268-76. PubMed ID: 8704183 [TBL] [Abstract][Full Text] [Related]
5. Improved diagnostic segregation of mantle cell lymphoma by determination of cyclin D1/D3 expression ratio in formalin-fixed tissue. Mangseth K; Helgeland L; Klos J; Molven A; Vintermyr OK Diagn Mol Pathol; 2009 Sep; 18(3):150-5. PubMed ID: 19704260 [TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. de Boer CJ; van Krieken JH; Kluin-Nelemans HC; Kluin PM; Schuuring E Oncogene; 1995 May; 10(9):1833-40. PubMed ID: 7753558 [TBL] [Abstract][Full Text] [Related]
7. The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements. Swerdlow SH; Zukerberg LR; Yang WI; Harris NL; Williams ME Am J Surg Pathol; 1996 May; 20(5):627-40. PubMed ID: 8619427 [TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 protein expression in mantle cell lymphoma. Alkan S; Schnitzer B; Thompson JL; Moscinski LC; Ross CW Ann Oncol; 1995 Jul; 6(6):567-70. PubMed ID: 8573535 [TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Yang WI; Zukerberg LR; Motokura T; Arnold A; Harris NL Am J Pathol; 1994 Jul; 145(1):86-96. PubMed ID: 7518196 [TBL] [Abstract][Full Text] [Related]
10. Immunoreactivity for cyclin D3 is frequently detectable in high-grade primary gastric lymphomas in the absence of the t(6;14)(p21.1;q32.3) chromosomal translocation. Pruneri G; Fabris S; Fasani R; Del Curto B; Capella C; Pozzi B; Motta T; Andreola S; Ferreri AJ; Ponzoni M; Viale G; Neri A J Pathol; 2003 Aug; 200(5):596-601. PubMed ID: 12898595 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma. Nakamura S; Seto M; Banno S; Suzuki S; Koshikawa T; Kitoh K; Kagami Y; Ogura M; Yatabe Y; Kojima M Jpn J Cancer Res; 1994 Dec; 85(12):1270-9. PubMed ID: 7531681 [TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow. Vasef MA; Medeiros LJ; Koo C; McCourty A; Brynes RK Am J Clin Pathol; 1997 Sep; 108(3):302-7. PubMed ID: 9291459 [TBL] [Abstract][Full Text] [Related]
13. [Detection of cyclin D1 mRNA by reverse transcription-polymerase chain reaction in paraffin-embedded tissues and its diagnostic significance for mantle cell lymphoma]. Shui RH; Wei YK; Sun MH; Wang J; Shi DR; Zhang TM; Jin AP; Zhu XZ Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):514-8. PubMed ID: 16383299 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of cyclin D2 in chronic B-cell malignancies. Delmer A; Ajchenbaum-Cymbalista F; Tang R; Ramond S; Faussat AM; Marie JP; Zittoun R Blood; 1995 May; 85(10):2870-6. PubMed ID: 7742549 [TBL] [Abstract][Full Text] [Related]
15. Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma. Uchimaru K; Taniguchi T; Yoshikawa M; Asano S; Arnold A; Fujita T; Motokura T Blood; 1997 Feb; 89(3):965-74. PubMed ID: 9028328 [TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. Zukerberg LR; Yang WI; Arnold A; Harris NL Am J Clin Pathol; 1995 Jun; 103(6):756-60. PubMed ID: 7540362 [TBL] [Abstract][Full Text] [Related]
17. Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes. Metcalf RA; Zhao S; Anderson MW; Lu ZS; Galperin I; Marinelli RJ; Cherry AM; Lossos IS; Natkunam Y Mod Pathol; 2010 Mar; 23(3):420-33. PubMed ID: 20062012 [TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement. Williams ME; Swerdlow SH Ann Oncol; 1994; 5 Suppl 1():71-3. PubMed ID: 8172823 [TBL] [Abstract][Full Text] [Related]
19. bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma. Ott MM; Helbing A; Ott G; Bartek J; Fischer L; Dürr A; Kreipe H; Müller-Hermelink HK J Pathol; 1996 Jul; 179(3):238-42. PubMed ID: 8774476 [TBL] [Abstract][Full Text] [Related]
20. The expression of SOX11, cyclin D1, cyclin D2, and cyclin D3 in B-cell lymphocytic proliferative diseases. Cao X; Fan L; Fang C; Zhu DX; Dong HJ; Wang DM; Wang YH; Xu W; Li JY Med Oncol; 2012 Jun; 29(2):1190-6. PubMed ID: 21479697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]